References
Schaake-Koning C, van de Boogaert W, Dalesio O, et al.: Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992, 326:524–530.
Uitterhoeve ALJ, Belderbos JSA, Koolen MGJ, et al.: Toxicity of high-dose radiotherapy combined with daily cisplatin in non-small cell lung cancer: results of the EORTC 08912 phase I/II study. Eur J Cancer 2000, 36:592–600.
Morris M, Eifel PJ, Lu J, et al.: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999, 340:1137–1143.
Rose PG, Bundy BN, Watkins EB, et al.: Concurrent cisplatinbased radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999, 340:1144–1153.
Keys HM, Bundy BN, Stehman FB, et al.: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999, 340:1154–1161.
Thomas GM: Concurrent chemotherapy and radiation for locally advanced cervical cancer: the new standard of care. Semin Radiat Oncol 2000, 10:44–50.
Eifel PJ, Rose PG: Chemotherapy and radiation therapy for cervical cancer. In ASCO Educational Book. Alexandria, VA:ASCO; 2000:199–206.
Pignon JP, Bourhis J, Domenge C, et al.: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000, 355:949–955.
Urba SG: Concurrent chemoradiation for head and neck cancer. In ASCO Educational Book. Alexandria, VA; 2000:215–218.
Robbins KT, Kumar P, Regine WF, et al.: Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys 1997, 38:263–271.
Al-Sarraf M, Pajak TF, Marcial VA, et al.: Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck: RTOG study. Cancer 1987, 59:259–265.
van de Vaart PJ, Belderbos J, de Jong D, et al.: DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy. Int J Cancer 2000, 20:160–166.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schornagel, J.H., Verheij, M. & Bartelink, H. Concurrent chemotherapy and radiation for locally advanced squamous cell cancers: what is the schedule of choice?. Curr Oncol Rep 3, 1–2 (2001). https://doi.org/10.1007/s11912-001-0034-3
Issue Date:
DOI: https://doi.org/10.1007/s11912-001-0034-3